he sun

he sun


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
WLWenjing Liao
Wenjing Liao
XMXiaohui Ma
Xiaohui Ma
JLJu Li
Ju Li
XLXinxin Li
Xinxin Li
ZGZhixin Guo
Zhixin Guo
HShe sun
he sun
Chronic stable angina (CSA) presents as a complication of coronary heart disease, leading to a high incidence and mortality rate worldwide. Dantonic® or Compound Danshen Dripping Pills (CDDP) is a well-known traditional Chinese medicine used for the treatment of myocardial ischemic diseases, such as angina pectoris (AP), myocardial infarction, and sudden death. Dantonic® has been extensively utilized in clinical practice in China for more than 14 years and has proved to be an effective therapy for the treatment of many myocardial ischemic diseases since its approval by CFDA in 1994. Clinical studies in China have shown that Dantonic® is an effective and safe drug for the treatment of angina pectoris manifested with ameliorating anginal symptoms and showing few adverse effects. Nevertheless, the mechanism of Dantonic® for the treatment of angina has been underestimated. Therefore, in this review, we mainly focus on discussing the pharmacological mechanism of action (MoA) of Dantonic® for the treatment of CSA, including the promotion of coronary microcirculation, the optimization of myocardial energy metabolism, and the inhibition of platelet aggregation.

10 November 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
EYErnesto Yagüe
Ernesto Yagüe
HShe sun
he sun
YHYUNHUI HU
YUNHUI HU
Traditional Chinese medicine (TCM) has used herbal remedies for more than 2,000 years. The use of complimentary therapies has increased dramatically during the last years, especially in the West, and the incorporation and modernization of TCM in current medical practice is gaining momentum. We reflect on the main bottlenecks in the modernization of arcane Chinese herbal medicine: lack of standardization, safety concerns and poor quality of clinical trials, as well as the ways these are being overcome. Progress in these areas will facilitate the implementation of an efficacy approach, in which only successful clinical trials lead to the molecular characterization of active compounds and their mechanism of action. Traditional pharmacological methodologies will produce novel leads and drugs, and we describe TCM successes such as the discovery of artemisinin as well as many others still in the pipeline. Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s disease, cancer and cardiovascular disease are the main cause of mortality in the Western world and, with an increasing old population in South East Asia, this trend will also increase in the Far East. TCM has been used for long time for treating these diseases in China and other East Asian countries. However, the holistic nature of TCM requires a paradigm shift. By changing our way of thinking, from “one-target, one-drug” to “network-target, multiple-component-therapeutics,” network pharmacology, together with other system biology methodologies, will pave the way toward TCM modernization.

1 January 2021 in Pharmaceutical Biology
Verified
Journal Article
Open access
YHYUNHUI HU
YUNHUI HU
JSJia Sun
Jia Sun
TWTongxing Wang
Tongxing Wang
HWHairong Wang
Hairong Wang
CZChunlai Zhao
Chunlai Zhao
HShe sun
he sun
Previous studies indicate that compound Danshen Dripping Pill (CDDP) improves the adaptation to high-altitude exposure. However, its mechanism of action is not clear.To explore the protective effec...

26 April 2024 in Phytomedicine
Verified
Journal Article
Closed access
QZQian Zhao
Qian Zhao
YHYunhui Hu
Yunhui Hu
YYYiman Yan
Yiman Yan
XSXujiao Song
Xujiao Song
JYJie Yu
Jie Yu
HShe sun
he sun

18 April 2024 in World Journal of Traditional Chinese Medicine
Verified
Journal Article
Closed access
MLMeng-Hua Li
Meng-Hua Li
WWWan-Qi Wang
Wan-Qi Wang
LZLi-Ting Zheng
Li-Ting Zheng
MCMeng-Bing Chen
Meng-Bing Chen
YCYang Chu
Yang Chu
XSXi Shi
Xi Shi
Objective: This study aimed to explore andrographolide’s mechanism of action and its protective effect on noise-induced hearing loss (NIHL). Materials and Methods: A mice animal model for NIHL was established through exposure to broadband noise at 120 dB sound pressure level for 4 h. Transcriptomics analysis and pharmacodynamic experiments were carried out. Results: Andrographolide enters the inner ear and effectively prevents hearing damage following noise exposure in the mice model for permanent hearing loss. Moreover, treatment with andrographolide inhibited the excessive activation of inflammatory factors in the cochleae of noise-exposed mice. Conclusion: Andrographolide might be a promising candidate for auditory protective drug investigation.

19 December 2019 in Preprints.org
Verified
Preprint
Open access
PDF file
YHYunhui Hu
Yunhui Hu
JSjia sun
jia sun
TWTongxing Wang
Tongxing Wang
HWHairong Wang
Hairong Wang
CZChunlai Zhao
Chunlai Zhao
HShe sun
he sun
Hypoxia is the main survival challenge that human beings encounter in high altitudes, it is also the leading cause of Acute Mountain Sickness (AMS). Studies have shown that hypoxia induces a large number of reactive oxygen species (ROS) in AMS patients, and the surge of ROS leads to the reduction of oxygen delivery capacity of erythrocyte, senescence and inflammatory impairment of erythrocyte and vascular endothelial cells to a certain extent. Through depicting a target-pathway network, our study indicates that Compound Danshen Dropping Pills (CDDP), which is one of the best-known traditional Chinese medicine used for the treatment of myocardial ischemic diseases, can improve red blood cell oxygen delivery capacity in AMS patients, alleviate tissue and organ damage, relieve a series of clinical symptoms caused by hypoxia through ROS clearance and related mechanisms. We further elucidate the active ingredients of CDDP targeting ROS related pathway by target-ingredient correspondence analysis. Tanshinone IIA, catechol and some other compounds of CDDP were identified to have certain targeting effect on ROS and ROS dependent pathways. This study provides new understandings of CDDP in clinical application on AMS.